Home

Vista Pharmaceuticals Ltd PE Ratio

Image

Vista Pharmaceuticals Ltd

NSE: VISTAPHARMA

PE

-

Last updated on: Apr 19, 2025

Key Highlights

  • The P/E Ratio of Vista Pharmaceuticals Ltd is 0 as of 19 Apr 11:41 AM .
  • The P/E Ratio of Vista Pharmaceuticals Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Latest Trading Price of Vista Pharmaceuticals Ltd is ₹ 11.3 as of 17 Apr 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 26.9. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 159.2. The PE Ratio of Textiles industry is 37.1 in 2024.

Historical P/E Ratio of Vista Pharmaceuticals Ltd

No data available

Company Fundamentals for Vista Pharmaceuticals Ltd

Image

Vista Pharmaceuticals Ltd

NSE: VISTAPHARMA

Share Price

₹ 11.3

0.37 (3.39%)

stock direction

Last updated on: Apr 17, 2025

Market Price of Vista Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Vista Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
17 Apr 202511.3
16 Apr 202510.93
15 Apr 202511.5
11 Apr 202511.8
09 Apr 202511.5
08 Apr 202511.81
07 Apr 202512.22
04 Apr 202512.49
03 Apr 202511.94
02 Apr 202511.43

SWOT Analysis Of Vista Pharmaceuticals Ltd

Strength

0

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Vista Pharmaceuticals Ltd

Asset Value vs Market Value of Vista Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Vista Pharmaceuticals Ltd43.87
Sun Pharmaceutical Industries Ltd420136
Divis Laboratories Ltd149680
Cipla Ltd122390
Torrent Pharmaceuticals Ltd110154
Mankind Pharma Ltd106555

PE Ratio of Vista Pharmaceuticals Ltd Explained

43.87

Market cap

-3

Earnings

0.0X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Vista Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Vista Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Vista Pharmaceuticals Ltd

No data available

* All values are in %

About Vista Pharmaceuticals Ltd

  • Vista Pharmaceuticals Limited was incorporated on January 25,1991 with the Registrar of Companies, Andhra Pradesh & has obtained Certificate of Commencement of Business on February 7, 1991.
  • The Company is engaged in the formulation of pharmaceutical products.
  • It offers a range of products mainly into the therapeutic areas of gastrointestinal, pain management and anti-infection, catering to common ailments.
  • This division is a primary contributor to the domestic sales of Torrent Pharmaceuticals Ltd., based in Hyderabad, India. The Company was in process of setting up a 100% EOU for manufacture of drug formulations with an installed capacity of 400 million tablets & 200 million capsules per annum.
  • Apart from these, the Company offers over the counter & prescription generic drug products consisting of tablets, capsules and liquids covering various therapeutic categories.

Vista Pharmaceuticals Ltd News Hub

Vista Pharmaceuticals reports standalone net loss of Rs 0.86 crore in the June 2024 quarter

Net Loss of Vista Pharmaceuticals reported to Rs 0.86 crore in the quarter ended June 2024 as agains

Read more

14 Aug 24

Vista Pharmaceuticals to discuss results

Vista Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August 2024

Read more

06 Aug 24

Vista Pharmaceuticals to conduct AGM

Vista Pharmaceuticals announced that the 33th Annual General Meeting (AGM) of the company will be he

Read more

10 Sept 24

Vista Pharmaceuticals reports standalone net loss of Rs 0.97 crore in the September 2024 quarter

Net Loss of Vista Pharmaceuticals reported to Rs 0.97 crore in the quarter ended September 2024 as a

Read more

14 Nov 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Vista Pharmaceuticals Ltd

What is the current PE Ratio of Vista Pharmaceuticals Ltd?

The Current PE Ratio of Vista Pharmaceuticals Ltd is 0.0 as on 19 Apr 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 19 Apr 2025.

What was the PE Ratio of Vista Pharmaceuticals Ltd last year?

The PE Ratio of Vista Pharmaceuticals Ltd was 0.0 last year, now the PE ratio is 0.0, showing a year-on-year growth of -%.

What does the PE Ratio of Vista Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Vista Pharmaceuticals Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of Vista Pharmaceuticals Ltd.

What is the PE Ratio Growth of Vista Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Vista Pharmaceuticals Ltd grew by -% whereas, the EPS ratio grew by -56.3.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions